Oncology/Hematology

Prostate Cancer

More in Prostate Cancer

Cardiorespiratory Fitness Levels May Influence Cancer Risk in Men

Higher cardiorespiratory fitness linked to lower risk of death from colon, lung, prostate cancers

Jun 29, 2023
A photo of a man and woman riding bicycles together.
'Redlining' and Cancer Screening; Talzenna OK'd for mCRPC; Genomic Testing Misused

News, features, and commentary about cancer-related issues

Jun 22, 2023
Onco Break over a computer rendering of a cancer cell.
Drug Shortage Worsens; AI, 3D Printing Potential Grows; Cancer's Effect on Function

News, features, and commentary about cancer-related issues

Jun 08, 2023
Onco Break over a computer rendering of a cancer cell.
Burnout: The Musical; Debt Ceiling May Stymie Research; Diet's 'Powerful Ability'

News, features, and commentary about cancer-related issues

Jun 02, 2023
Onco Break over a computer rendering of a cancer cell.
End Out-of-Pocket Costs; Reducing Cancer-Related Fatigue; One-and-Done HPV Vax?

News, features, and commentary about cancer-related issues

May 26, 2023
Onco Break over a computer rendering of a cancer cell.
Certain Toxic Effects Higher With Newer Prostate Cancer Therapies

Systematic reviews suggests increased risks of cognitive adverse events, fatigue, falls

May 26, 2023
A computer rendering of prostate cancer.
Lumpers vs Splitters: Categorizing Prostate Cancer

Should very low-risk and low-risk be combined into one?

May 19, 2023
A computer rendering of prostate cancer.
Drug Shortages Hit Oncology; Telemedicine Tops In-Person; Sniffing Out Lung Cancer

News, features, and commentary about cancer-related issues

May 12, 2023
Onco Break over a computer rendering of a cancer cell.
World's Smallest Skin Cancer; Exercise Boosts Immune Cells; Cannabis and Pain Relief

News, features, and commentary about cancer-related issues

May 05, 2023
Onco Break over a computer rendering of a cancer cell.
Enzalutamide-ADT Cuts Risk for Disease Spread in Nonmetastatic Prostate Cancer

Combo has potential to be new standard of care in patients with high-risk BCR, expert says

Apr 30, 2023
AUA over a photo of McCormick Place in Chicago, Illinois
FDA Panel Rejects Broad Olaparib Indication in Metastatic CRPC

ODAC votes that olaparib-abiraterone combination should be restricted to BRCA-positive subset

Apr 28, 2023
FDA olaparib (Lynparza) + abiraterone (Zytiga) over a computer rendering of prostate cancer.
Vit D and PD-1 Blockade; Low Implant-Related SCC Risk; Better Pay for Unused Meds

News, features, and commentary about cancer-related issues

Apr 28, 2023
Onco Break over a computer rendering of a cancer cell.
FDA Staff Not Sold on Broad Olaparib Indication in Metastatic CRPC

Agency asking ODAC if olaparib-abiraterone should be reserved for BRCA-positive subset

Apr 27, 2023
FDA olaparib (Lynparza) + abiraterone (Zytiga) over a computer rendering of prostate cancer.
Talc-Cancer Lawsuits on Hold; Diet & Prostate Cancer; Active Surveillance Deep Dive

News, features, and commentary about cancer-related issues

Apr 21, 2023
Onco Break over a computer rendering of a cancer cell.
More in Prostate Cancer

Continuing Medical Education

0.50 CME Credits
Integrating Novel Classes of Immunotherapy Into Treatment Paradigms in Advanced/Metastatic Melanoma

0.50 CME Credits
Expert Strategies to Monitor and Mitigate Adverse Events During Breast Cancer Treatment

0.50 CME Credits
Clinical Case Challenge: Applying the Latest Evidence to Improve Outcomes in BRAF Mutant Advanced Melanoma

0.50 CME Credits
Immunotherapy in Advanced Melanoma: Evidence-Based Adverse Event Management Strategies to Improve Patient Outcomes

1.00 CME Credits
Expert Perspectives in Managing Lower-Risk Myelodysplastic Syndromes

0.50 CME Credits
Integrating the Latest Evidence into Patient-Centered Treatment for Advanced/Metastatic Triple Negative Breast Cancer

0.50 CME Credits
Evidence-Based Strategies to Improve Outcomes for Patients With Gastroesophageal Cancers

1.00 CME Credits
Incorporating Recent Data Into Current Treatment Paradigms in Melanoma